These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2556972)

  • 1. [HCFU and 5-fluorouracil levels in the blood and tissue of hepatocellular carcinoma after oral administration of HCFU].
    Mori M; Hamazaki K; Mimura H; Orita K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3763-8. PubMed ID: 2556972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [5-FU and HCFU concentrations in serum and tissues in hepatocellular carcinoma after HCFU oral administration].
    Suenaga M
    Gan No Rinsho; 1988 May; 34(6):744-8. PubMed ID: 2837592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma.
    Takenaka K; Kanematsu T; Shimada M; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1191-5. PubMed ID: 2548869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum concentration of HCFU and 5-FU after oral administration of HCFU in postoperative digestive cancer patients].
    Kuroda Y; Ohkuma R; Ohsato K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1831-6. PubMed ID: 1519925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
    Onji M; Kondo H; Yamashita Y; Ohta Y; Mori K; Fuse M
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2063-72. PubMed ID: 3005446
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
    Akiharu W; Higashi T; Kobayashi M; Nakatsukasa H; Fujiwara M; Shiota T; Yamauchi Y; Ito T; Yamamoto H; Nagashima H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2506-12. PubMed ID: 6095760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfer of carmofur (HCFU) to the serum, bile, pancreatic juice and pancreatic tumor tissue in the cases of peri-pancreatic head cancer].
    Akaishi S; Kobari M; Yusa T; Yamanami H; Furukawa T; Matsuno S
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):659-64. PubMed ID: 7717718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative clinical study on 5-FU concentrations for oral HCFU and i.v. 5-FU].
    Miyauchi M; Yamamoto N; Matsumoto M; Shishikura T; Hyakutake K
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1011-4. PubMed ID: 10925686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the optimum method of administration of a new antineoplastic agent, HCFU, based on the serum 5-FU concentration following oral administration].
    Hara Y; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):293-300. PubMed ID: 7184403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
    Sakurai K; Yoshiga K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-FU concentration in portal blood after oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
    Seo Y; Hara Y; Furusawa M; Nakane H; Saeki K; Tsujitani S; Sonoda T; Nohtsuka T; Kameda K; Tomoda H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1803-5. PubMed ID: 2453163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of urokinase on the transfer of 1-hexylcarbamoyl-5-fluorouracil (HCFU) into the blood, bile and pancreatic juice].
    Kato S; Matsuno S; Kakizaki K; Fukaya Y; Akaishi S
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2134-8. PubMed ID: 4062312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in mice.
    Iigo M; Nakamura A; Kuretani K; Hoshi A
    Xenobiotica; 1980 Nov; 10(11):847-54. PubMed ID: 7467400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 5-FU concentrations in sera and resected specimens from patients with ovarian tumors].
    Takizawa K; Ino Y; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):697-702. PubMed ID: 3355187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1-Hexylcarbamoyl-5-fluorouracil (HCFU) effective in hepatocellular carcinoma metastatic to the lungs--a case report].
    Higashi H; Takenaka K; Kanematsu T; Matsumata T; Yoshida Y; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2956-9. PubMed ID: 2821925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.